Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti–CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study
| Title: | Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti–CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study |
|---|---|
| Authors: | Rovin, Brad H. 1, ∗; Boxhammer, Rainer 2; Thakur, Anjali 2; Ronco, Pierre M. 3, 4 |
| Source: | In Kidney International Reports September 2022 7(9):2086-2090 |
| Database: | ScienceDirect |